News

Cold Spring Harbor Laboratory Licenses Epistemic AI Research Intelligence Platform

Epistemic AI (EAI) is pleased to announce that the Cold Spring Harbor Laboratory (CSHL) has licensed its Research Intelligence platform. With support from the Boomer Esiason Foundation (BEF), the EAI platform will help researchers at CSHL to rapidly access documents and data that provide insight into the underlying relationships among diseases, their diagnosis, treatments, and biological functions. The BEF venture philanthropy model was an instrumental component to bring this enhanced capability to CSHL.

Epistemic AI cited in important paper investigating the biological role of the glaucoma-associated glycoprotein Myocilin.

In a multi-university study of Myocilin, the authors noted that “to unveil functional relationships in the group of top-100 DEGs (top-50 up- plus top-50 down-regulated genes), we carried out a comprehensive enrichment analysis using Epistemic AI, an artificial intelligence web-based software platform”.

Raquel Atienzar-Aroca, et al. Transgenic Overexpression of Myocilin Leads to Variable Ocular Anterior Segment and Retinal Alterations Associated with Extracellular Matrix Abnormalities in Adult Zebrafish. Int J Mol Sci. 2022 Sep 1;23(17):9989.

Press Release - July 18, 2022

Epistemic AI launches strategic collaboration with Cincinnati Children’s Hospital Medical Center

Epistemic AI (EAI) announced that through its collaboration with the Boomer Esiason Foundation (BEF), and the leadership of Dr. Raouf Amin at Cincinnati Children’s Hospital Medical Center, that the Cincinnati Children’s Division of Pulmonary Medicine will use the EAI platform to augment and accelerate their research in Cystic Fibrosis (CF) and respiratory disease. Epistemic AI will bring AI-powered knowledge discovery to researchers and clinicians in cystic fibrosis.